Group 7 Copy 3 Created with Sketch.

MENU
Centers
Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous
News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions

Advertisement

Search Results

Refine by Content Type

close Created with Sketch.

Refine by Year

close Created with Sketch.

Sort By:

Relevance Date

Choose Sites to Search:

EVToday EVToday + CIToday

Sponsored by Medtronic

evt | Article | June 2019

Leveraging Vascular Access Clinical Trial Endpoints to Enhance Innovation

By Prabir Roy-Chaudhury, MD, PhD

Sponsored by Gore & Associates

evt | Article | June 2016 Supplement

Vascular Access Innovation in a Changing Health Care Environment

An opinion piece describing how global payment systems could potentially incentivize vascular access innovation.

By Prabir Roy-Chaudhury, MD, PhD

evt | Article | June 2017

Economics and the Next Decade of Dialysis Access Intervention

A brief perspective on how health care economics will affect dialysis access in the United States.

By Prabir Roy-Chaudhury, MD, PhD

evt | Article | June 2016

Why Aren't There More Effective Therapies for Dialysis Vascular Access Dysfunction?

Collaboration and a precision medicine approach could be the keys to improving dialysis vascular access care.

By Prabir Roy-Chaudhury, MD, PhD

Advertisement

evt | Article | June 2020

Roundtable Discussion: ESRD in the Age of the COVID-19 Pandemic

Managing patient needs, coagulation concerns, telemedicine use, and a look at what we can learn from the pandemic.

With Dirk M. Hentschel, MD; Karen Woo, MD, MS, DFSVS, FACS; and Prabir Roy-Chaudhury, MD, PhD, FRCP (Edin)

evt | Article | June 2017

Ask the Experts: What Outcomes Will Foster or Stymie Adoption of Drug-Coated Balloons in AV Fistula Intervention?

Experts discuss how patency, cost-effectiveness, and reimbursement may impact if and when DCBs are used.

With Scott O. Trerotola, MD; Kate Steiner, BSc, MBBS, MRCP, FRCR; Andrew Holden, MBChB, FRANZCR, EBIR; and Prabir Roy-Chaudhury, MD, PhD

evt | News | August 30, 2015

NIH Grant Will Support Symic Biomedical's Development of Therapeutic Agent to Reduce Vascular Access Failures in End-Stage Renal Disease

August 26, 2015—Symic Biomedical, Inc. announced that it has received a $1.5 million phase 2 small-business innovation research grant from the National Institutes of Health (NIH) to further develop its therapeutic agent to reduce arteriovenous fistula failures in patients with end-stage renal disease undergoing hemodialysis.

evt | Article | June 2017

Dialogues in Dialysis Access

By Bart Dolmatch, MD, FSIR

evt | Article | June 2020

Maintaining Progress in Challenging Times

By Bart Dolmatch, MD, and Stephen E. Hohmann, MD, FACS

evt | News | August 12, 2022

Gore Acquires InnAVasc Medical

August 12, 2022—Gore & Associates announced the acquisition of InnAVasc Medical, Inc., a privately-held medical technology company focused on care for patients with end-stage renal disease who utilize graft circuits for dialysis treatment.

Sponsored by Medtronic

evt | Article | January 2020

Medtronic Medical Affairs Corner: A Year in Review

Advertisement

Cardiac Interventions Today
Group 7 Copy 3 Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button